AstraZeneca’s COVID-19 vaccine trial could be ready to resume this week in the US after a seven-week hiatus while the FDA completed its review of a serious illness, according to reports.
Eli Lilly has put a clinical trial of its COVID-19 antibody therapy on hold after FDA inspectors found serious quality control problems at the plant, according to press reports.
The World Health Organisation has halted clinical tests of hydroxychloroquine against COVID-19, after safety concerns emerged in a study of medication feted by president Donald Trump as a w
As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
